ENDRA Life Sciences (NDRA) Inventory Average (2017 - 2024)

ENDRA Life Sciences (NDRA) has reported Inventory Average for 8 consecutive years, with $2.7 million the latest figure, recorded in Q3 2024.

• On a quarterly basis, Inventory Average fell 1.66% year-over-year to $2.7 million in Q3 2024; TTM through Sep 2024 was $2.7 million, a 1.66% decrease from a year earlier, with the FY2023 full-year figure at $2.6 million, up 34.06% from the prior year.
• Inventory Average was $2.7 million for Q3 2024 at ENDRA Life Sciences, roughly flat from $2.7 million in the prior quarter.
• Over five years, Inventory Average peaked at $2.8 million in Q3 2023 and troughed at $144188.5 in Q1 2020.
• A 5-year average of $1.8 million and a median of $2.2 million in 2022 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average jumped 356.43% in 2021 and slipped 1.66% in 2024, its largest moves.
• Over 5 years, Inventory Average stood at $456414.0 in 2020, then surged by 205.02% to $1.4 million in 2021, then soared by 89.59% to $2.6 million in 2022, then climbed by 1.93% to $2.7 million in 2023, then increased by 0.81% to $2.7 million in 2024.
• The last three Inventory Average figures came in at $2.7 million (Q3 2024), $2.7 million (Q2 2024), and $2.7 million (Q1 2024), per Business Quant data.